SCHEMBL17431197

SCHEMBL17431197

c1ccc2c(c1)oc1ccc3c(c12)-c1c(ccc2c1sc1ccccc12)-c1ccc2c(sc4ccccc42)c1-c1c-3ccc2oc3ccccc3c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.37
▸ CDC25A P30304 1/20 0.35
▸ CDC25B P30305 1/20 0.35
▸ CDC25C P30307 1/20 0.35
▸ ALOX5 P09917 1/20 0.35
▸ ESR2 Q92731 2/20 0.35
▸ MAPT P10636 5/20 0.34
▸ PRKDC P78527 4/20 0.34
▸ ALDH1A1 P00352 4/20 0.33
▸ HPGD P15428 4/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ GLA P06280 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ PGAM1 P18669 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ ESR1 P03372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17930627 0.84 GPR3 (0.45) GPR3ALOX5ESR2MAPTPRKDC
SCHEMBL19108950 0.83 GPR3 (0.43) GPR3ALOX5ESR2MAPTPRKDC
SCHEMBL17431198 0.82 ESR2 (0.40) GPR3CDC25ACDC25BCDC25CALOX5
SCHEMBL17431156 0.82 GPR3 (0.54) GPR3ALOX5MAPTPRKDCALDH1A1
SCHEMBL17431201 0.82 MAPT (0.42) GPR3CDC25ACDC25BCDC25CALOX5
SCHEMBL17431154 0.80 MAOA (0.48) CDC25ACDC25BCDC25CMAPTALDH1A1
SCHEMBL17431196 0.80 AHR (0.41) GPR3CDC25ACDC25BCDC25CALOX5
SCHEMBL17431190 0.80 AHR (0.41) GPR3CDC25ACDC25BCDC25CALOX5
SCHEMBL17431146 0.79 GPR3 (0.50) GPR3ALOX5MAPTPRKDCALDH1A1
SCHEMBL19108789 0.79 L3MBTL1 (0.41) GPR3ALOX5ESR2MAPTPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10566546-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-02-18 — — US disclosed
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-01-14 — — US disclosed
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OXER1, NR4A3, OXSR1 GPR3 164/4885CDC25A 3896/4885CDC25B 4080/4885
US-10566546-B2 Organic electroluminescent materials and devices OXER1, NR4A3, OXSR1 GPR3 164/4885CDC25A 3896/4885CDC25B 4080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback